The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Assessment of the role of α2‐adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice
Open accessAbstract
The role of α 2‐adrenoceptor (AR) subtypes in the modulation of acute nociception, motor behaviour and body temperature, has been investigated by determining the activity of the α 2 AR selective agonist dexmedetomidine (Dex) in mice devoid of individual α 2 AR subtypes through either a point (α 2A) or null (α 2B/α 2C) mutation (‘knock‐out’). In a rodent model of acute thermal nociception, the mouse tail immersion test, Dex, in wild type (WT) control animals, produced a dose‐dependent increase in the threshold for tail withdrawal from a 52°C water bath with mean ED 50 values of 99.9±14.5 (α 2A), 94.6±17.8 (α 2B) and 116.0±17.1 (α 2C) μg kg−1, i.p. In comparison to the WT controls, Dex (100–1000 μg kg−1, i.p.), was completely ineffective as an antinociceptive agent in the tail immersion test in the α 2A AR D79N mutant animals. Conversely, in the α 2B AR and α 2C AR knock‐outs, Dex produced a dose‐dependent antinociceptive effect that was not significantly different from that observed in WT controls, with ED 50 values of 85.9±15.0 (P>0.05 vs WT control) and 226.0±62.7 (P>0.05 vs WT control) μg kg−1 i.p., respectively. Dex (10–300 μg kg−1, i.p.) produced a dose‐dependent reduction in spontaneous locomotor activity in the α 2A, α 2B and α 2C AR WT control animals with ED 50 values of 30.1±9.0, 23.5±7.1 and 32.3±4.6 μg kg−1, i.p., respectively. Again, Dex (100–1000 μg kg−1, i.p.) was ineffective at modulating motor behaviour in the α 2A AR D79N mutants. In the α 2B AR and α 2C AR knock‐out mice, Dex produced a dose‐dependent reduction in spontaneous locomotor activity with ED 50 values of 29.1±6.4 (P>0.05 vs WT control) and 57.5±11.3 (P>0.05 vs WT control) μg kg−1, respectively. Dex was also found to produce a dose‐dependent reduction in body temperature in the α 2A, α 2B and α 2C AR WT control mice with ED 50 values of 60.6±11.0, 16.2±2.5 and 47.2±9.1 μg kg−1, i.p., respectively. In the α 2A AR D79N mutants, Dex had no effect on body temperature at a dose (100 μg kg−1, i.p.) that produced a significant reduction (−6.2±0.5°C; P<0.01 vs vehicle) in temperature in WT controls. However, higher doses of Dex (300 and 1000 μg kg−1, i.p) produced a small, but statistically significant decrease in temperature corresponding to −1.7±0.4°C and −2.4±0.3°C (both P<0.01 vs vehicle), respectively. In the α 2B AR and α 2C AR knock‐out mice, Dex produced a dose‐dependent reduction in body temperature with ED 50 values of 28.4±4.8 (P>0.05 vs WT control) and 54.1±8.0 (P>0.05 vs WT control) μg kg−1, respectively. In conclusion, the data are consistent with the α 2A AR being the predominant subtype involved in the mediation of the antinociceptive, sedative and hypothermic actions of Dex. This profile would appear to indicate that an α 2A AR subtype selective analgesic will have a narrow therapeutic window, particularly following systemic administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
Gerlai, R. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20020-7 · Cited by 881
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
The induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774
Pertovaara, A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.08.001 · Cited by 597
Bhana, N., Goa, K. L., & McClellan, K. J. (2000) · Drugs · doi:10.2165/00003495-200059020-00012 · Cited by 597
Physiological significance of α2-adrenergic receptor subtype diversity: one receptor is not enough
Philipp, M., Brede, M., & Hein, L. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00123.2002 · Cited by 318
Metadata
- Authors
- Hunter, J. C., Fontana, D. J., Hedley, L. R., Jasper, J. R., Lewis, R., Link, R. E., Secchi, R., Sutton, J., & Eglen, R. M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-12
- Volume
- 122
- Issue
- 7
- Pages
- 1339-1344
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2023358654
- Cited by
- 294
- References
- 1
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of the role of α2‐adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. https://app.cochat.ai/papers/10.1038/sj.bjp.0701520
- The paper
- Hunter, J. C., Fontana, D. J., Hedley, L. R., Jasper, J. R., Lewis, R., Link, R. E., Secchi, R., Sutton, J., & Eglen, R. M. (1997). Assessment of the role of α2‐adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0701520
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.